GLP-1 receptor agonists in hypertrophic cardiomyopathy: Mortality benefit with complex cardiovascular risk profile

Authors

• Karldon Iwuchukwu Nwaezeapu
• Godbless Ajenaghughrure
• Ekow Essien, Advocate Health - MidwestFollow
• Abena Agyekum

Recommended Citation

Nwaezeapu KI, Ajenaghughrure G, Essien E, Agyekum A. GLP-1 Receptor Agonists in Hypertrophic Cardiomyopathy: Mortality Benefit with Complex Cardiovascular Risk Profile. American Heart Journal. 2025;290:7-8. doi:10.1016/j.ahj.2025.07.028

Type

Abstract